Prediction of the effects of gonadotropin-releasing hormone agonist therapy in uterine leiomyoma by T1 contrast-enhanced magnetic resonance imaging sequences

By Kadowaki M.   Murakami T.   Morita J.   Terada Y.   Yaegashi N.   Okamura K.  

Fertility and Sterility, Vol. 77, Iss. 5, 2002-05 ,pp. : 1081-1082

Elsevier

Access to resources Recommend Favorite

Spontaneous expulsion of a uterine submucosal leiomyoma after administration of a gonadotropin-releasing hormone agonist

By Yu K.-J.   Lai C.-R.   Sheu M.-H.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 96, Iss. 2, 2001-06 ,pp. : 223-225

Elsevier

Access to resources Recommend Favorite

Ultrastructural comparison of uterine leiomyoma cells from the same myoma nodule before and after gonadotropin-releasing hormone agonist treatment

By Ito F.   Kawamura N.   Ichimura T.   Tsujimura A.   Ishiko O.   Ogita S.  

Fertility and Sterility, Vol. 75, Iss. 1, 2001-01 ,pp. : 125-130

Elsevier

Access to resources Recommend Favorite

Effects of a Gonadotropin-Releasing Hormone agonist and Follicle Stimulating Hormone on the incidence of apoptosis in human luteinized granulosa cells

By Sifer C.   Blanc-Layrac G.   Bringuier A.-F.   Porcher R.   Madelenat P.   Feldmann G.   Benifla J.-L.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 110, Iss. 1, 2003-09 ,pp. : 43-48

Elsevier

Access to resources Recommend Favorite

The comparison of gonadotropin-releasing hormone agonist therapy and intraperitoneal Ringer's lactate solution in prevention of postoperative adhesion formation in rat models

By Canbaz M.A.   Ustun C.   Kocak I.   Yanik F.F.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 82, Iss. 2, 1999-02 ,pp. : 219-222

Elsevier

Access to resources Recommend Favorite